\n\n\n\n\t\t\n\t\t\tTacere Therapeutics\n\t\t\thttp://www.tacerebio.com/\n\t\t
\n\t\t\n\t\t\tWatch Company\n\t\t\tGet Widget\n\t\t
\n\tTacere is an innovative biotechnology company focused on developing therapeutics to treat serious infectious diseases using its proprietary knowledge in the screening and development of both novel and...More»
\n\t\t\tTacere is an innovative biotechnology company focused on developing therapeutics to treat serious infectious diseases using its proprietary knowledge in the screening and development of both novel and traditional compounds. Tacere is located in San Jose, California, USA. Its lead therapeutic compound is TT-033i, an RNA interference (RNAi) drug for the treatment of Hepatitis C. Tacere balances traditional and novel approaches to treating HCV using internal expertise in research and development coupled with its extensive academic and clinical alliances. Unlike small molecule drugs, RNAi allows you to target multiple regions of HCV simultaneously, making the therapeutic effective for a far more diverse patient population. Additionally, the multitargeting approach creates a \u201ccocktail in one drug\u201d similar to HIV drug regimens. Tacere founders pioneered the application of RNAi for infectious diseases and have developed a clinically relevant means of systemic delivery for TT-033i.«Less
\n\n\t\t\tOverview
\n\t\t\t\tLocation: \tSan Jose, CA, United States\n
\n\t\t\t\tIndustry: Biopharmaceuticals
\n\t\t\t\tTags:\n\t\t\t\tbiotech,\n\t\t\t\ttherapeutics,\n\t\t\t\tproprietary,\n\t\t\t\tcompounds,\n\t\t\t\tdrugs,\n\t\t\t\tmedical,\n\t\t\t\tscreening,\n\t\t\t\thepatitis c,\n\t\t\t\tinfectious diseases\n\t\t\t\t
\n\t\t\tFinancials
\n\t\t\t\tLatest Funding: Series A - $-1M (10/12/2006)
\n\t\t\t\tInvestors:\n\t\t\t\t\t\n\t\tHokkaido Venture Capital\n\t\t\t\t
\n\t\t\tMarket
\n\t\t\t\tCompetitors:\n\t\t\t\t\t\tTaiGen Biotechnology\n\t\t\t\t
\n\n\t\t\t\tRelated Companies:\n\t\t\t\t\tSynosia Therapeutics,\n\t\t\t\t\tAscenta Therapeutics,\n\t\t\t\t\tBioLineRx,\n\t\t\t\t\tNumerate,\n\t\t\t\t\tAcologix,\n\t\t\t\t\tNuon Therapeutics,\n\t\t\t\t\tNeose Technologies,\n\t\t\t\t\tDirect Therapeutics,\n\t\t\t\t\tTheravance,\n\t\t\t\t\tOcera Therapeutics\n\t\t\t\t
\n\t\t\t